A Bioinformatics Resource for TWEAK-Fn14 Signaling Pathway. (9th May 2012)

• Record Type: Journal Article
• Authors: Bhattacharjee, Mitali; Raju, Rajesh; Radhakrishnan, Aneesha; Nanjappa, Vishalakshi; Muthusamy, Babylakshmi; Singh, Kamlendra; Kuppusamy, Dheebika; Lingala, Bhavya Teja; Pan, Archana; Mathur, Premendu Prakash; Harsha, H. C.; Prasad, T. S. Keshava; Atkins, Gerald J.; Pandey, Akhilesh; Chatterjee, Aditi
• Other Names: Yoshimura A. Academic Editor.
• Is Part Of: Journal of signal transduction. Volume 2012(2012)
• Publication Date: 2012-05-09
• Subjects: Cellular signal transduction -- Periodicals; Signal Transduction; Cellular signal transduction; Periodical; Periodicals; Electronic journals; 616.0277
• DOI: 10.1155/2012/376470
• Languages: English
• ISSNs: 2090-1739

Abstract

Abstract : TNF-related weak inducer of apoptosis (TWEAK) is a new member of the TNF superfamily. It signals through TNFRSF12A, commonly known as Fn14. The TWEAK-Fn14 interaction regulates cellular activities including proliferation, migration, differentiation, apoptosis, angiogenesis, tissue remodeling and inflammation. Although TWEAK has been reported to be associated with autoimmune diseases, cancers, stroke, and kidney-related disorders, the downstream molecular events of TWEAK-Fn14 signaling are yet not available in any signaling pathway repository. In this paper, we manually compiled from the literature, in particular those reported in human systems, the downstream reactions stimulated by TWEAK-Fn14 interactions. Our manual amassment of the TWEAK-Fn14 pathway has resulted in cataloging of 46 proteins involved in various biochemical reactions and TWEAK-Fn14 induced expression of 28 genes. We have enabled the availability of data in various standard exchange formats from NetPath, a repository for signaling pathways. We believe that this composite molecular interaction pathway will enable identification of new signaling components in TWEAK signaling pathway. This in turn may lead to the identification of potential therapeutic targets in TWEAK-associated disorders.